Gene Symbol | IGFBP2 |
Entrez ID | 3485 |
Uniprot ID | P18065 |
Description | insulin like growth factor binding protein 2 |
Chromosomal Location | chr2: 216,632,828-216,664,436 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001558 |
regulation of cell growth |
Any process that modulates the frequency, rate, extent or direction of cell growth. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
IEA |
BP |
GO:0007565 |
female pregnancy |
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
IEA |
BP |
GO:0007568 |
aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
IEA |
BP |
GO:0007584 |
response to nutrient |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
IEA |
BP |
GO:0009612 |
response to mechanical stimulus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
IEA |
BP |
GO:0010226 |
response to lithium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
IEA |
BP |
GO:0032355 |
response to estradiol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
IEA |
BP |
GO:0032526 |
response to retinoic acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
IEA |
BP |
GO:0032870 |
cellular response to hormone stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
IEA |
BP |
GO:0042104 |
positive regulation of activated T cell proliferation |
Any process that activates or increases the rate or extent of activated T cell proliferation. |
IDA |
BP |
GO:0042493 |
response to drug |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IEA |
BP |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway |
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling. |
IBA|IC|ISS |
BP |
GO:0043627 |
response to estrogen |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
IEA |
BP |
GO:0044267 |
cellular protein metabolic process |
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
TAS |
BP |
GO:0051384 |
response to glucocorticoid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
IEA |
BP |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
TAS |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
ISS|TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
CC |
GO:0016324 |
apical plasma membrane |
The region of the plasma membrane located at the apical end of the cell. |
IEA |
CC |
GO:0031410 |
cytoplasmic vesicle |
A vesicle found in the cytoplasm of a cell. |
IEA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
TAS |
MF |
GO:0031994 |
insulin-like growth factor I binding |
Interacting selectively and non-covalently with insulin-like growth factor I. |
IDA |
MF |
GO:0031995 |
insulin-like growth factor II binding |
Interacting selectively and non-covalently with insulin-like growth factor II. |
IBA|ISS |
Domain ID | Description |
---|---|
IPR000716 |
Thyroglobulin type-1 |
IPR000867 |
Insulin-like growth factor-binding protein, IGFBP |
IPR009030 |
Growth factor receptor cysteine-rich domain |
IPR009168 |
Insulin-like growth factor binding protein |
IPR012210 |
Insulin-like growth factor binding protein 2 |
IPR017891 |
Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site |
IPR022321 |
Insulin-like growth factor-binding protein family 1-6, chordata |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
WP289 |
Myometrial Relaxation and Contraction Pathways |
WikiPathways |
WP3614 |
Photodynamic therapy-induced HIF-1 survival signaling |
WikiPathways |
h_ghrelinPathway |
Ghrelin: Regulation of Food Intake and Energy Homeostasis |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0010606 |
Adenoid Cystic Carcinoma |
C0011616 |
Contact Dermatitis |
C0021655 |
Insulin Resistance |
C0023893 |
Liver Cirrhosis, Experimental |
C0028754 |
Obesity |
C0036095 |
Salivary Gland Neoplasms |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
25393639 |
Ambekar et al. |
2014 |
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
GSDMB |
55876 |
Q8TAX9 |
0.63 |
IGF1 |
3479 |
P05019 |
0.49 |
KLK2 |
3817 |
P20151 |
0.52 |
TF |
7018 |
P02787 |
0.52 |
IGF2 |
3481 |
P01344 |
0.66 |
INO80B |
83444 |
Q9C086 |
0.78 |